MAS

Clinical trials for MAS explained in plain language.

Never miss a new study

Get alerted when new MAS trials appear

Sign up with your email to follow new studies for MAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New drug targets deadly immune storm in rare inflammatory diseases

Disease control Completed

This study tested a drug called emapalumab in 33 children and adults with a dangerous immune overreaction (macrophage activation syndrome) caused by Still's disease or lupus. The goal was to see if the drug could calm the immune system and improve blood test results when standard…

Matched conditions: MAS

Phase: PHASE3 • Sponsor: Swedish Orphan Biovitrum • Aim: Disease control

Last updated May 22, 2026 13:54 UTC

MAS

Get alerted when new MAS trials appear

New drug targets deadly immune storm in rare inflammatory diseases